VivoSeq
Other

THL

0

Pipeline Programs↗

0

Active Trials↗

1

Companies Involved↗

THL is an early-stage landscape with 0 programs across 1 company. The most active players are Amgen.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Amgen logo

Amgen

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed3 · 60%
Unknown status2 · 40%

Clinical Trials

Trial Activity

Beclomethasone in Healthy Athletes
Unknown status·—·Phase 4·NCT05352191·30 enrolled
Escalating Monthly Doses of Tafenoquine in Healthy Volunteers
Unknown status·NNaval Medical Research Center·Phase 4·NCT05203744·200 enrolled
A Study of Econazole Foam 1% in Athlete's Foot
Completed·AAmDerma·Phase 2·NCT00768599·135 enrolled
The Role of Nasal Breathing for Perfomance in Elite Athletes.
Completed·SSahlgrenska University Hospital·N/A·NCT06480071·12 enrolled
Aranesp® Monthly Preference Study - 2
Completed·Amgen logoAmgen·Phase 4·NCT00117078

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)